Meeting
2019 ASCO Annual Meeting
Activity of hormonal treatment in uterine smooth muscle tumors of uncertain malignant potential (STUMP): A mono-institutional referral center experience in advanced disease.
Authors
Roberta Sanfilippo
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Roberta Sanfilippo , Marta Sbaraglia , Elena Fumagalli , Giacomo Giulio Baldi , Giovanni Fucà , Carlo Morosi , Marta Barisella , Angelo Paolo Dei Tos , Paolo Giovanni Casali
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Citation
J Clin Oncol 37, 2019 (suppl; abstr 11066)
DOI
10.1200/JCO.2019.37.15_suppl.11066
Abstract #
11066
Poster Bd #
389
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib (2ND-STEP, JCOG1802).
First Author: Makoto Endo
Poster
2023 ASCO Annual Meeting
Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy.
First Author: Kristine Peregrino Lacuna
Poster
2016 ASCO Annual Meeting
Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.
First Author: Maristella Saponara
Poster
2016 ASCO Annual Meeting
Efficacy of front-line chemotherapy for recurrent/metastatic adenosarcoma of the uterus.
First Author: Michael Nathenson